Nalbuphine ER demonstrated a highly significant and consistent reduction in chronic cough associated with IPF, but final study results should be awaited [ 12 ].
← all excerpts
ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly.
1
—
—